this post was submitted on 16 Sep 2023
1169 points (96.1% liked)

Technology

59605 readers
3385 users here now

This is a most excellent place for technology news and articles.


Our Rules


  1. Follow the lemmy.world rules.
  2. Only tech related content.
  3. Be excellent to each another!
  4. Mod approved content bots can post up to 10 articles per day.
  5. Threads asking for personal tech support may be deleted.
  6. Politics threads may be removed.
  7. No memes allowed as posts, OK to post as comments.
  8. Only approved bots from the list below, to ask if your bot can be added please contact us.
  9. Check for duplicates before posting, duplicates may be removed

Approved Bots


founded 1 year ago
MODERATORS
 

Researchers from Pritzker Molecular Engineering, under the guidance of Prof. Jeffrey Hubbell, demonstrated that their compound can eliminate the autoimmune response linked to multiple sclerosis. Researchers at the University of Chicago's Pritzker School of Molecular Engineering (PME) have developed

you are viewing a single comment's thread
view the rest of the comments
[–] aksdb@feddit.de 3 points 1 year ago (2 children)

That would also work for cancer then, wouldn't it? Since the mutated cells hide from the immune system you can mark a few to get the immune system to take a look and realize that shit is happening, or am I oversimplifying too much?

[–] BroccoliFarts@lemmy.world 4 points 1 year ago

There are immunotherapy treatments for cancer already. Infections and cancer use the immune system the correct way: "tag" the problem cell/virus part with an antibody, make a lot more antibody and flood your body with it to clear the problem cell/virus.

This is the process a vaccine uses. The old vaccine method is to take a bunch of dead bacteria or inactivated virus and put that in your body. Your body should identify it and begin making antibodies against it. If you do get exposed to the disease, your body is full of antibodies which can immediately clear it, rather than letting the infection/cancer work for a few days without much of an immune response.

An autoimmune disease, a body "tags" its own cells. Then the immune system invades the person's own tissue.

I have celiac disease. If I eat gluten, the enzymes I use to digest gluten become tagged. Unfortunately, humans make one gluten enzyme (TG2) that's found everywhere in the body. A third of celiacs will have their thyroid tissue affected if they consume gluten.

One particular antibody, IgE, is known for extreme reactions to antigens. These are the ones known for the immediate and life-threatening allergies (peanuts, shellfish, bees, wheat).

This new stuff appears to be a way to tag antibodies or antigens or memory T cells (they hold the "blueprints" to make antibodies really quickly after your natural antibodies go away) and have the immune system "re-evaluate" the antigen. I'm guessing from the post above and a little of the article. I haven't heard of this process in the body before.

Cancer itself is not autoimmune (autoimmune inflammation can make it more likely to happen, but tumors don't form directly through autoimmune mechanisms). So the first pathway used for normal vaccination is what's needed. The difficulty lies in knowing something in each specific cancer that would make a good antibody target. It is a person's own cells and DNA, so a lot of care has to be taken to find an appropriate antigen. Immunotherapy treatments that exist are really specific to certain types of cancer. They have much less severe side effects than radiotherapy and chemotherapy.

[–] stoneparchment@possumpat.io 1 points 1 year ago

You're not oversimplifying from my description, my description was just too simple itself! Unfortunately, no, it wouldn't work like this. The whole idea is that the cell would pick up anything and discover that it isn't as dangerous as it thought. That's the opposite of what we'd want for cancer cells!

Luckily, there are many, many other treatments for various cancers coming in due time, also. My research is actually closer to cancer research than immunology, so I can tell ya-- there's good stuff coming!